Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Neurological Disorders
AI neuroimaging model aims to predict neuropathic pain treatment responses
A magnetic resonance (MR) neuroimaging model which uses artificial intelligence (AI) to identify new biomarkers could lead to more effective medical treatment for chronic nerve pain, say the researchers developing the model.
August 25, 2023
Blood test detects neurometabolic disease to simplify, accelerate diagnosis
A study compared a blood test METAglut1, which quantifies GLUT1 on the surface of red blood cells, to glycorrhachia measured via lumbar puncture in a prospective cohort of 428 patients and a retrospective cohort of 67 patients.
June 6, 2023
Serum assay may enable the diagnosis of neurodegenerative diseases
An assay that detects minute concentrations of alpha synuclein seeds in blood serum may enable quicker diagnosis of neurodegenerative disorders.
May 30, 2023
A closer look at long COVID symptoms
Intensively studied patients with persistent post-COVID neurological symptoms were found to have autonomic dysfunction and differences in their immune cell profiles.
May 10, 2023
Indiana University, MindX Sciences researchers developing blood test for anxiety
A blood test for anxiety may determine an individual’s risk of developing anxiety, and which therapies might treat it most effectively, the researchers said.
March 8, 2023
Study supports genetic testing for people with cerebral palsy
A meta-analysis of recent cerebral palsy research suggests that genetic testing could be offered as the standard procedure for people with the disorder.
March 7, 2023
Quanterix Q4 revenues drop 15% but match analysts’ expectations
For full-year 2022, total revenue was $105.5 million, a decline of 5% compared with 2021 revenue that included $5.2 million in National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) grant money.
March 6, 2023
Invitae announces data on epilepsy genetic testing outcomes
Among patients whose treatment was changed based on genetic testing, 75% reported positive health outcomes, including 65% who saw a reduction in frequency -- even elimination -- of seizures.
November 1, 2022
Variantyx obtains $20M in funding
Whole genome sequencing tracks changes in genes that can cause disease. Variantyx is developing the testing method for the diagnosis of rare inherited and neurological disorders, it said.
March 15, 2021
Researchers outline neurological signs of COVID-19
The neurological complications of COVID-19 are becoming more obvious as the pandemic wears on, and they consist of a startling range of conditions, according to a team led by Ross Paterson, PhD, of University College London.
July 8, 2020
Real-world study: Genetic testing appears underused in autism
Neurological medicine researchers evaluated how frequently chromosomal microarray (CMA) and fragile X syndrome testing were conducted in people with autism spectrum disorder through the Rhode Island Consortium for Autism Research and Treatment (RI-CART). Results were reported by Dr. Eric Morrow, PhD, head of the Developmental Disorders Genetics Research Program at Brown University, and colleagues in a research letter.
May 13, 2020
Pathology study challenges conventional wisdom on brain injury
The prospective Traumatic Head Injury Neuroimaging Classification (THINC) study was funded by the U.S. Department of Defense and the National Institute of Neurological Disorders and Stroke (NINDS).
October 14, 2019
Page 1 of 2
Next Page
